Influence of Tobacco Smoking on the Development of Obstructive Sleep Apnea (OSA)

The aim of this study was to retrospectively evaluate the influence of Tobacco Smoking on the development of Obstructive Sleep Apnea (OSA).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obstructive Sleep Apnea Apnea Behavior Dyssomnias Nervous System Diseases Respiration Disorders Respiratory Tract Diseases Sleep Apnea Syndromes Sleep Apnea, Obstructive Sleep Disorders, Intrinsic Sleep Wake Disorders Tobacco Use

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

The aim of this study was to retrospectively evaluate the influence of Tobacco Smoking on the development of Obstructive Sleep Apnea (OSA).

Statistical analysis will be performed on this retrospective population to determine in tobacco smoking could influence the development of OSA.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients for a preoperative anesthetic consultation between 01/01/14 and 31/12/17 who undergo a polysomnography

Exclusion criteria

None

Treatment and study plan

Tobacco Smoking

Other

Influence of Tobacco Smoking on the development of OSA

Primary outcomes

Obstructive Sleep Apnea (OSA)

Time frame: 1 month

Diagnosis of OSA based on a polysomnography recording

Sponsors and collaborators

Lead sponsor

Astes

Other

Registry information

Important dates

Study start: 2014
Primary completion: 2017
Study completion: 2018
First posted: Jul 2, 2018
Registry last updated: Jul 3, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed